|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1997-5-12
|
|
pubmed:abstractText |
Oxipurinol has been shown to be sufficiently absorbed after oral administration as a rapid release preparation of oxipurinol sodium. We compared the uric acid lowering affect of allopurinol and oxipurinol.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0315-162X
|
|
pubmed:author |
pubmed-author:ErnstBB,
pubmed-author:FreiMM,
pubmed-author:KoleTT,
pubmed-author:KosmowskaBB,
pubmed-author:PriebeUU,
pubmed-author:SchroderH EHE,
pubmed-author:SlottyCC,
pubmed-author:VossAA,
pubmed-author:Walter-SackII,
pubmed-author:WeberAA,
pubmed-author:WegscheiderKK,
pubmed-author:de VriesJ XJX
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
23
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
498-501
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:8832991-Adult,
pubmed-meshheading:8832991-Aged,
pubmed-meshheading:8832991-Allopurinol,
pubmed-meshheading:8832991-Cross-Over Studies,
pubmed-meshheading:8832991-Double-Blind Method,
pubmed-meshheading:8832991-Enzyme Inhibitors,
pubmed-meshheading:8832991-Hematocrit,
pubmed-meshheading:8832991-Humans,
pubmed-meshheading:8832991-Leukocyte Count,
pubmed-meshheading:8832991-Male,
pubmed-meshheading:8832991-Middle Aged,
pubmed-meshheading:8832991-Oxypurinol,
pubmed-meshheading:8832991-Therapeutic Equivalency,
pubmed-meshheading:8832991-Uric Acid
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
Uric acid lowering effect of oxipurinol sodium in hyperuricemic patients - therapeutic equivalence to allopurinol.
|
|
pubmed:affiliation |
Medizinische Klinik und Poliklinik, Abteilung Klinische Pharmakologie, Ruprecht-Karls-Universitat Heidelberg, Germany.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Multicenter Study
|
